dr. dang on neratinib in patients with her2 breast cancer
Published 7 years ago • 453 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:42
dr. dang on the destiny-breast01 trial in her2 metastatic breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
1:12
dr. nye on neratinib-associated diarrhea in her2 breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:38
dr. shao on managing toxicity with neratinib in her2 breast cancer
-
1:41
dr. hurvitz on toxicity associated with neratinib in her2 breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
1:03
dr. barcenas on neratinib-related diarrhea in her2 breast cancer
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer
-
4:09
her2 breast cancer: neratinib patient selection
-
1:44
dr. blackwell on neratinib in her2 breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
8:12
her2 breast cancer: neratinib’s role as adjuvant therapy
-
0:25
copy of dr. shao on managing toxicity with neratinib in her2 breast cancer
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease